Micregen
PrivateLast Round
VC Round
Apr 1, 2021
Est. Valuation
$124.61M
Total Funding Raised
$1.96M
Company Overview
Micregen is a biotechnology company that develops stem cell-derived secretome therapeutics for regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Micregen Comparables
Compare Micregen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Secretome Therapeutics | 82% | |
| Immunis, Inc. | 81% | |
| Noveome Biotherapeutics | 81% |
Micregen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 1, 2021 | ||||
| Seed | Apr 1, 2020 | ||||
| Seed | Feb 1, 2017 | ||||
| Seed | Sep 28, 2016 |
Micregen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pitalia Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2024
Grew 150% QoQ, from 2 to 5 employees.
- Sep 28, 2016
$1.43M raised in Seed funding.
Micregen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Micregen's valuation, stock price, and market status.
Is Micregen a public or private company?
Micregen is a private company.
What is the current stock price of Micregen?
Micregen is a private company, so its shares have no public market price. Caplight tracks Micregen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Micregen worth (valuation)?
Micregen's valuation is estimated at $124.6M based on funding round data.
Can I buy Micregen stock?
Micregen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Micregen's last funding round?
Micregen's most recent funding round was VC Round on April 1, 2021.
Who are the main investors in Micregen?
Key investors in Micregen include Pitalia Capital.
Will Micregen IPO soon?
No public IPO plans have been announced for Micregen.
How can I track Micregen secondary market activity?
Caplight tracks bids, offers, and trades in Micregen's shares on secondary markets.